An abortion provider and lawmakers in North Carolina are pushing a federal judge to decide if new state restrictions on the use of an abortion-inducing drug can survive in light of a federal regulatory scheme covering the medication.
The federal Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for mifepristone preempts
North Carolina’s latest anti-abortion statute, physician Amy Bryant and state Attorney General Josh Stein (D) told the US District Court for the Middle District of North Carolina in separate post-hearing briefs Monday.
The state law, however, “works in tandem” with the federal Food and Drug Administration’s regulations to ...